RE: Phase III Trial30 Nov 2020 14:48
I'm still confused by the Phase III trial scope - what is the concensus? Maybe more will be revealed in this afternoon's NIHR Zoom meeting. Apologies if already discussed and resolved, and I missed it. (So many posts on here)
1. NIHR supported the Phase II trial and is supporting Phase III trial: "The phase 3 trial is expected to involve 900 participants and will take place across up to 20 NHS sites." from their own web site today)
2. Paraxel is working with Synairgen to run Phase III trials globally "... the trial is expected to enroll 900 patients across approximately 20 countries ..." from their own web site, Oct 20.
So ... to me this definitely means there are TWO separate Phase III arms which has to be a good thing. Hopefully the UK trials will be soon underway and our hospitals will realises just what a tool they have available to prevent many patients progressing to ventilators.
Your thoughts?